BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7050938)

  • 1. [Advances in nephrology. Lupus nephritis].
    Siciński A
    Pol Arch Med Wewn; 1982 Mar; 67(3):125-31. PubMed ID: 7050938
    [No Abstract]   [Full Text] [Related]  

  • 2. [Changes of renal histological findings, serum C3, C4 level in patients with lupus nephritis by steroid therapy].
    Sueishi M; Tomioka H; Yanagisawa T; Nawata Y; Kagami M; Koike T; Takabayashi K; Yoshida S; Kumagai A; Tsuchida H
    Nihon Jinzo Gakkai Shi; 1984 Apr; 26(4):343-52. PubMed ID: 6471579
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunopathology of the kidney in disseminated lupus erythematosus].
    Morel-Maroger L; Méry JP
    Pathol Biol (Paris); 1975 Jun; 23(6):492-3. PubMed ID: 1105354
    [No Abstract]   [Full Text] [Related]  

  • 4. Determination of circulating immune complexes, C3 and C4 complement components and anti-DNA antibody in different classes of lupus nephritis.
    Klein MH; Thorner PS; Yoon SJ; Poucell S; Baumal R
    Int J Pediatr Nephrol; 1984 Jun; 5(2):75-82. PubMed ID: 6333404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Plasma level of complement fractions C3 and C4 in children with glomerular nephropathies. Correlations with morphological and immunopathological studies of renal biopsies].
    Loirat C; Levy M
    Arch Fr Pediatr; 1976 Nov; 33(G):853-72. PubMed ID: 827270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Murine lupus nephritis. Effects of glucocorticoid on circulating and tissue-bound immunoreactants.
    Cavallo T; Graves K; Granholm NA
    Lab Invest; 1983 Oct; 49(4):476-81. PubMed ID: 6604840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical course of lupus nephritis: relationship to the renal histologic findings.
    Pollak VE; Pirani CL; Dujovne I; Dillard MG
    Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):1167-81. PubMed ID: 4139685
    [No Abstract]   [Full Text] [Related]  

  • 8. New approaches to clinical pathologic correlation in lupus nephritis.
    Kashgarian M
    Am J Kidney Dis; 1982 Jul; 2(1 Suppl 1):164-9. PubMed ID: 6213151
    [No Abstract]   [Full Text] [Related]  

  • 9. [Significance of the study of complement in glomerulonephritis. Research on some serum complement fractions and their detection in renal biopsies with the use of microscopy and immunofluorescence].
    Martini PF; Camussi G; Segoloni G; Rotunno M; Triolo G; Mangiarotti G; Messina M; Caramello E
    Recenti Prog Med; 1978 Mar; 64(3):354-73. PubMed ID: 351753
    [No Abstract]   [Full Text] [Related]  

  • 10. Focal mesangiopathic glomerulonephritis: prevalence and pathogenesis.
    Germuth FG; Rodriguez E
    Kidney Int; 1975 Apr; 7(4):216-23. PubMed ID: 1142639
    [No Abstract]   [Full Text] [Related]  

  • 11. The significance of serial measurements of serum complement C3 and C4 components and DNA binding capacity in patients with lupus nephritis.
    Garin EH; Donnelly WH; Shulman ST; Fernandez R; Finton C; Williams RL; Richard GA
    Clin Nephrol; 1979 Oct; 12(4):148-55. PubMed ID: 315852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement deposition in the kidney.
    Berger J
    Adv Nephrol Necker Hosp; 1974; 4():37-48. PubMed ID: 4219998
    [No Abstract]   [Full Text] [Related]  

  • 13. Anti-DNA antibodies and renal lesions of patients with systemic lupus erythematosus.
    Koffler D; Agnello V; Carr RI; Kunkel HG
    Transplant Proc; 1969 Dec; 1(4):933-8. PubMed ID: 4939688
    [No Abstract]   [Full Text] [Related]  

  • 14. Murine lupus nephritis: effects of cyclophosphamide on circulating and tissue bound immunoreactants.
    Cavallo T; Graves K; Granholm NA
    Clin Exp Immunol; 1984 Jan; 55(1):67-73. PubMed ID: 6607142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Properdin levels in systemic lupus erythematosus and membranoproleferative glomerulonephritis.
    Perrin LH; Lambert PH; Miescher PA
    Clin Exp Immunol; 1974 Apr; 16(4):575-81. PubMed ID: 4219766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression of mesangial and focal to diffuse lupus nephritis.
    Ginzler EM; Nicastri AD; Chen CK; Friedman EA; Diamond HS; Kaplan D
    N Engl J Med; 1974 Oct; 291(14):693-6. PubMed ID: 4604972
    [No Abstract]   [Full Text] [Related]  

  • 17. Murine lupus nephritis: effect of azathioprine on glomerular permeability and localization of immunoreactants.
    Cavallo T; Graves K; Granholm NA
    Clin Exp Immunol; 1983 Sep; 53(3):547-54. PubMed ID: 6616955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of autoimmune diseases with anti-idiotypic antibodies: murine lupus nephritis as a model.
    Hahn BH
    Springer Semin Immunopathol; 1984; 7(1):25-34. PubMed ID: 6377539
    [No Abstract]   [Full Text] [Related]  

  • 19. Is renal biopsy overused in patients with systemic lupus erythematosus?
    Kühn K; Menninger H
    Contrib Nephrol; 1984; 43():45-50. PubMed ID: 6386328
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunoglobulin and complement deposits in lupus glomerulonephritis.
    Méry JP; Morel-Maroger L; Boelaert J
    Proc Eur Dial Transplant Assoc; 1975; 11():506-11. PubMed ID: 1197274
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.